PDF(557 KB)
PDF(557 KB)
PDF(557 KB)
我国微生物产业发展战略研究
Development Strategy of Microbial Industry in China
微生物产业作为战略性新兴产业，是我国培育发展新动能、打造全球竞争新优势的重要领域。在推进健康中国建设的重大机遇面前，发展微生物产业对于区域科技创新、产业高质量发展、保障健康并改善民生等具有积极意义。本文阐述了微生物产业发展的宏观需求，从产业布局、技术进展角度梳理了国际微生物产业发展现状，进而总结产业发展趋势；从产业政策环境、产业规模的角度概括我国微生物产业发展态势，对微生物安全、微生物健康、微生物制造、微生物医药等产业细分方向的发展现状进行调研，据此剖析发展面临的挑战。研究认为，建设系统化的大科学设施、发展产业化的系列技术、推动微生物资源的产业化应用，是我国微生物产业发展的关键举措。加强微生物高技术产业关键核心技术研发，推动建立协同创新发展的产业政策体系，围绕微生物创新平台实施创新驱动并集中打造产业集群，对提升我国微生物产业发展水平具有重要作用。
The microbial industry is a strategic emerging industry and it is an important field for developing new growth drivers and for creating new global competitive advantages. In the face of the great opportunity to promote the construction of Healthy China, the development of the microbial industry is significant for regional scientific and technological innovation, high-quality industrial development, and improvement of people’s welfare in China. The study expounded the macro-demand for the development of microbial industry and analyzed the development status of the global microbial industry in terms of industrial layout and technological progress. The study further outlined the development trend of the microbial industry in China from the aspects of industrial policy environment and industrial scale, investigated the development status of industrial segmentation directions including microbial safety, microbial health, microbial manufacturing, and microbial medicine, and dissected the challenges in the development of the industry. Our findings indicated that structuring systematic big science facilities, developing a series of industrialized technologies, and promoting the industrial application of microbial resources are key initiatives to accelerate the development of the microbial industry in China. We proposed to strengthen the research and development of key core technologies of the microbial high-tech industry, promote the establishment of an industrial policy system for collaborative innovation and development, and build industrial clusters centering around microbial innovation platforms, all of which will greatly improve the development level of microbial industry in China.
微生物产业 / 微生物安全 / 微生物健康 / 微生物医药 / 微生物制造 / 大科学设施 / 产业化应用
microbial industry / microbial safety / microbial health / microbial medicine / microbial manufacturing / big science facilities / industrial application
| [1] |
中华人民共和国国务院. 国务院关于印发“十三五”国家战 略性新兴产业发展规划的通知 [EB/OL]. (2016-11-29)[2021- 06-30]. http://www.gov.cn/zhengce/content/2016-12/19/content_5150090.htm. State Council of the People’s Republic of China. State Council’s circular on the publication of the national strategic emerging industries development plan for the 13th Five-Year Plan [EB/ OL]. (2016-11-29)[2021-06-30]. http://www.gov.cn/zhengce/content/2016-12/19/content_5150090.htm.
|
| [2] |
BCC Research. 微生物产品: 技术、应用、全球市场 [EB/OL]. (2018-07-10)[2021-06-30]. https://www.giichinese.com.cn/report/ bc180728-glob-microbial-prod.html. BCC Research. Microbial products: Technologies, applications and global markets [EB/OL]. (2018-07-10)[2021-06-30]. https:// www.giichinese.com.cn/report/bc180728-glob-microbial-prod. html.
|
| [3] |
申建波, 白洋, 韦中, 等. 根际生命共同体: 协调资源、环境和粮 食安全的学术思路与交叉创新 [J]. 土壤学报, 2021 (4): 1–11. Shen J B, Bai Y, Wei Z, et al. Rhizobiont: An interdisciplinary innovation and perspective for harmonizing resources, environment, and food security [J]. Acta Pedologica Sinica, 2021 (4): 1–11.
|
| [4] |
黎海芪. 微生物与人类健康息息相关 [J]. 临床儿科杂志, 2020, 38(7): 558–560. Li H Q. Microorganisms are closely related to human health [J]. Journal of Clinical Pediatrics, 2020, 38(7): 558–560.
|
| [5] |
黄瑞荣, 盛宣才, 任开磊, 等. 生物能源发展现状与战略思考 [J]. 林业机械与木工设备, 2021, 49(6): 15–20. Huang R R, Sheng X C, Ren K L, et al. Development status and strategic consideration bioenergy [J]. Forestry Machinery & Woodworking Equipment, 2021, 49(6): 15–20.
|
| [6] |
Perry R J, Peng L, Barry N A, et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome [J]. Nature, 2016, 534(7606): 213–217.
|
| [7] |
Sampson T R, Debelius J W, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a Model of parkinson’s disease [J]. Cell, 2016, 167(6): 1469–1480.
|
| [8] |
崔元培, 魏子鲲, 王建忠, 等. “双减”背景下化肥、农药施用现状 与发展路径 [J]. 北方园艺, 2021 (9): 164–173. Cui Y P, Wei Z K, Wang J Z, et al. Development status and path of application of chemical fertilizers and pesticides under the background of reduced [J]. Northern Horticulture, 2021 (9): 164– 173.
|
| [9] |
刘晓. 微生物菌肥在农业生产中的应用研究 [J]. 河南农业, 2021 (17): 14–15. Liu X. Research on application of microbial fertilizer in agricultural production [J]. Agriculture of Henan, 2021 (17): 14–15.
|
| [10] |
张汪强. 碳中和专题报告: 生物基行业, 潜力巨大的新蓝海 [EB/OL]. (2021-01-06)[2021-06-30]. https://baijiahao.baidu.com/ s?id=1688122811159329053. Zhang W Q. Special report on carbon neutrality: Bio-based industry, a new blue ocean with huge potential [EB/OL]. (2021-01-06)[2021- 06-30]. https://baijiahao.baidu.com/s?id=1688122811159329053.
|
| [11] |
张楠. 全球40家创新公司竞逐, 国内微生物组产业即将走向应 用爆发期 [EB/OL]. (2018-01-31)[2021-06-30]. https://www.sohu. com/a/219995596_397362. Zhang N. 40 innovative companies around the world are competing, the microbiome industry in China is about to enter a period of application outbreak [EB/OL]. (2018-01-31)[2021-06-30]. https:// www.sohu.com/a/219995596_397362.
|
| [12] |
观研产经研究院. 2021年中国微生物检测产业分析报告–行业 深度调研与发展趋势研究 [EB/OL]. (2021-02-08)[2021-06-30]. http://baogao.chinabaogao.com/shengwuzhiyao/532606532606. html. Guanyan Institute of Industrial Economics. 2021 analysis report on China’s microbial testing industry: Industry in-depth research and development trend research [EB/OL]. (2021-02-08)[2021-06-30]. http://baogao.chinabaogao.com/shengwuzhiyao/532606532606. html.
|
| [13] |
36氪. 益生菌市场将达574亿美元，如何用微生物的“洪荒之力” 在 食 品 界 创 新？ [EB/OL]. (2019-12-02)[2021-06-30]. https:// baijiahao.baidu.com/s?id=1651768007533849591&wfr=spider&-for=pc. 36 Krypton. The probiotic market will reach US $57.4 billion, how to use the “prehistoric power” of microorganisms to innovate in the food industry? [EB/OL]. (2019-12-02)[2021-06-30]. https:// baijiahao.baidu.com/s?id=1651768007533849591&wfr=spider&for=pc.
|
| [14] |
中国化工报.日照研讨生物化工发展 [EB/OL]. (2019-04-08) [2021-06-30]. http://www.ccin.com.cn/detail/5b2bf3244156eeaad89ffa5de68a078f/news. China Chemical Industry News. Research and development of biochemical engineering in Rizhao [EB/OL]. (2019-04-08)[2021- 06-30]. http://www.ccin.com.cn/detail/5b2bf3244156eeaad89ffa5d e68a078f/news.
|
| [15] |
方升研究. 年度产业观察: 转危为机的生物医药 [EB/OL]. (2021-08-10)[2021-08-30]. https://www.cn-healthcare.com/articlewm/20210809/content-1251175.html. Fang Sheng Research. Annual industry observation: Turning crisis into opportunity biomedicine [EB/OL]. (2021-08-10)[2021- 08-30]. https://www.cn-healthcare.com/articlewm/20210809/ content-1251175.html.
|
| [16] |
华大智造. 华大智造获颁全球华人生物学家大会“华人之光” 奖 [EB/OL]. (2019-07-31)[2021-06-30]. https://www.sohu.com/ a/330574738_299121. MGI. MGI was awarded the “Chinese Light” award at the global Chinese biologists conference [EB/OL]. (2019-07-31)[2021-06- 30]. https://www.sohu.com/a/330574738_299121.
|
| [17] |
马爱进, 韩盼盼, 刘杨柳, 等. 微生物健康产业发展态势与对策 建议 [J]. 食品科学, 2020, 41(17): 307–314. Ma A J, Han P P, Liu Y L, et al. Trends in the microbial health industry and countermeasures for its development [J]. Food Science, 2020, 41(17): 307–314.
|
| [18] |
贺绍杰, 曾艳玲. 微生物制药酵母菌渣工业化处理研究 [J]. 江 苏海洋大学学报(自然科学版), 2018, 27(2): 57–60. He S J, Zeng Y L. Study on the industrial treatment of microbial pharmaceutical yeast residue [J]. Journal of Jiangsu Ocean University(Natural Science Edition), 2018, 27(2): 57–60.
|
| [19] |
江洪波, 陈大明, 毛开云. 抗生素、氨基酸、维生素等大宗产品规 模化发展及产业情况 [J]. 生物产业技术, 2012 (1): 51–56. Jiang H B, Chen D M, Mao K Y. Large scale development and industrial situation of bulk products such as antibiotics, amino acids, and vitamins [J]. Biotechnology & Business, 2012 (1): 51–56.
|
| [20] |
陈凯先. 生物医药科技创新前沿、我国发展态势和新阶段的若 干思考 [J]. 中国食品药品监管, 2021 (8): 4–17. Chen K X. Advances in biopharmaceutical science and technology, innovative biologics in China and discussion of drug development at the new development stage [J]. China Food & Drug Administration Magazine, 2021 (8): 4–17.
|
/
| 〈 |
|
〉 |
